189 related articles for article (PubMed ID: 34799745)
1. Transoral incisionless fundoplication with Medigus ultrasonic surgical endostapler (MUSE) for the treatment of gastro-esophageal reflux disease: outcomes up to 3 years.
Testoni SGG; Cilona MB; Mazzoleni G; Fanti L; Ribichini E; Cavestro GM; Esposito D; Viale E; Notaristefano C; Zuppardo RA; Azzolini F; Passaretti S; Testoni PA
Surg Endosc; 2022 Jul; 36(7):5023-5031. PubMed ID: 34799745
[TBL] [Abstract][Full Text] [Related]
2. The long-term efficacy of transoral incisionless fundoplication with Medigus Ultrasonic Surgical Endostapler (MUSE) for gastroesophageal reflux disease.
Shen S; Yu G; Guo X; Zong G; Wang C; Bao J; Chen J; Cheng Z; Xiao W; Shen J; Jiang W; Wan R
Esophagus; 2023 Jul; 20(3):581-586. PubMed ID: 36877412
[TBL] [Abstract][Full Text] [Related]
3. Transoral incisionless fundoplication with an ultrasonic surgical endostapler for the treatment of gastroesophageal reflux disease: 12-month outcomes.
Testoni PA; Testoni S; Mazzoleni G; Pantaleo G; Cilona MB; Distefano G; Fanti L; Antonelli M; Passaretti S
Endoscopy; 2020 Jun; 52(6):469-473. PubMed ID: 32187630
[TBL] [Abstract][Full Text] [Related]
4. Long-term efficacy of transoral incisionless fundoplication with Esophyx (Tif 2.0) and factors affecting outcomes in GERD patients followed for up to 6 years: a prospective single-center study.
Testoni PA; Testoni S; Mazzoleni G; Vailati C; Passaretti S
Surg Endosc; 2015 Sep; 29(9):2770-80. PubMed ID: 25480624
[TBL] [Abstract][Full Text] [Related]
5. Randomized controlled trial of transoral incisionless fundoplication vs. proton pump inhibitors for treatment of gastroesophageal reflux disease.
Witteman BP; Conchillo JM; Rinsma NF; Betzel B; Peeters A; Koek GH; Stassen LP; Bouvy ND
Am J Gastroenterol; 2015 Apr; 110(4):531-42. PubMed ID: 25823768
[TBL] [Abstract][Full Text] [Related]
6. Effect of transoral incisionless fundoplication on symptoms, PPI use, and ph-impedance refluxes of GERD patients.
Testoni PA; Corsetti M; Di Pietro S; Castellaneta AG; Vailati C; Masci E; Passaretti S
World J Surg; 2010 Apr; 34(4):750-7. PubMed ID: 20091308
[TBL] [Abstract][Full Text] [Related]
7. Response of Laryngopharyngeal Symptoms to Transoral Incisionless Fundoplication in Patients with Refractory Proven Gastroesophageal Reflux.
Snow GE; Dbouk M; Akst LM; Ihde G; Zarnegar R; Janu P; Murray M; Eskarous H; Sohagia A; Dhar SI; Irene Canto M
Ann Otol Rhinol Laryngol; 2022 Jun; 131(6):662-670. PubMed ID: 34378427
[TBL] [Abstract][Full Text] [Related]
8. Long-term benefit of transoral incisionless fundoplication using the esophyx device for the management of gastroesophageal reflux disease responsive to medical therapy.
Stefanidis G; Viazis N; Kotsikoros N; Tsoukalas N; Lala E; Theocharis L; Fassaris A; Manolakopoulos S
Dis Esophagus; 2017 Feb; 30(3):1-8. PubMed ID: 27868281
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of Laparoscopic Nissen Fundoplication vs Transoral Incisionless Fundoplication or Proton Pump Inhibitors in Patients With Gastroesophageal Reflux Disease: A Systematic Review and Network Meta-analysis.
Richter JE; Kumar A; Lipka S; Miladinovic B; Velanovich V
Gastroenterology; 2018 Apr; 154(5):1298-1308.e7. PubMed ID: 29305934
[TBL] [Abstract][Full Text] [Related]
10. Endoscopic anterior fundoplication with the Medigus Ultrasonic Surgical Endostapler (MUSE™) for gastroesophageal reflux disease: 6-month results from a multi-center prospective trial.
Zacherl J; Roy-Shapira A; Bonavina L; Bapaye A; Kiesslich R; Schoppmann SF; Kessler WR; Selzer DJ; Broderick RC; Lehman GA; Horgan S
Surg Endosc; 2015 Jan; 29(1):220-9. PubMed ID: 25135443
[TBL] [Abstract][Full Text] [Related]
11. Transoral incisionless fundoplication effective in eliminating GERD symptoms in partial responders to proton pump inhibitor therapy at 6 months: the TEMPO Randomized Clinical Trial.
Trad KS; Barnes WE; Simoni G; Shughoury AB; Mavrelis PG; Raza M; Heise JA; Turgeon DG; Fox MA
Surg Innov; 2015 Feb; 22(1):26-40. PubMed ID: 24756976
[TBL] [Abstract][Full Text] [Related]
12. Transoral incisionless fundoplication (TIF 2.0) with EsophyX for gastroesophageal reflux disease: long-term results and findings affecting outcome.
Testoni PA; Vailati C; Testoni S; Corsetti M
Surg Endosc; 2012 May; 26(5):1425-35. PubMed ID: 22170317
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of endoscopic anterior fundoplication with a novel ultrasonic surgical endostapler for gastroesophageal reflux disease: Six-month results from a multicenter prospective trial.
Peng L; Wan R; Chen S; Wu J; Yang J; Wang X; Yan B; Zhao H; Pan F; Shi Y; Wang W; Ai J; Yang Y
Endosc Ultrasound; 2023; 12(1):128-134. PubMed ID: 36861512
[TBL] [Abstract][Full Text] [Related]
14. Laparoscopic Hiatal Hernia Repair Followed by Transoral Incisionless Fundoplication With EsophyX Device (HH + TIF): Efficacy and Safety in Two Community Hospitals.
Janu P; Shughoury AB; Venkat K; Hurwich D; Galouzis T; Siatras J; Streeter D; Korman K; Mavrelis G; Mavrelis P
Surg Innov; 2019 Dec; 26(6):675-686. PubMed ID: 31431138
[TBL] [Abstract][Full Text] [Related]
15. Three-year results of a multicenter prospective study of transoral incisionless fundoplication.
Muls V; Eckardt AJ; Marchese M; Bastens B; Buset M; Devière J; Louis H; Rajan A; Daniel MA; Costamagna G
Surg Innov; 2013 Aug; 20(4):321-30. PubMed ID: 22968006
[TBL] [Abstract][Full Text] [Related]
16. Transoral incisionless fundoplication for recurrent symptoms after laparoscopic fundoplication.
Ghosh G; Choi AY; Dbouk M; Greenberg J; Zarnegar R; Murray M; Janu P; Thosani N; Dayyeh BKA; Diehl D; Nguyen NT; Chang KJ; Canto MI; Sharaiha R;
Surg Endosc; 2023 May; 37(5):3701-3709. PubMed ID: 36650353
[TBL] [Abstract][Full Text] [Related]
17. A prospective multicenter registry of patients with chronic gastroesophageal reflux disease receiving transoral incisionless fundoplication.
Bell RC; Mavrelis PG; Barnes WE; Dargis D; Carter BJ; Hoddinott KM; Sewell RW; Trad KS; DaCosta Gill B; Ihde GM
J Am Coll Surg; 2012 Dec; 215(6):794-809. PubMed ID: 22939637
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of transoral incisionless fundoplication (TIF) for the treatment of GERD: a systematic review with meta-analysis.
Huang X; Chen S; Zhao H; Zeng X; Lian J; Tseng Y; Chen J
Surg Endosc; 2017 Mar; 31(3):1032-1044. PubMed ID: 27495332
[TBL] [Abstract][Full Text] [Related]
19. Randomised clinical trial: transoral incisionless fundoplication vs. sham intervention to control chronic GERD.
Håkansson B; Montgomery M; Cadiere GB; Rajan A; Bruley des Varannes S; Lerhun M; Coron E; Tack J; Bischops R; Thorell A; Arnelo U; Lundell L
Aliment Pharmacol Ther; 2015 Dec; 42(11-12):1261-70. PubMed ID: 26463242
[TBL] [Abstract][Full Text] [Related]
20. Clinical and pH-metric outcomes of transoral esophagogastric fundoplication for the treatment of gastroesophageal reflux disease.
Bell RC; Freeman KD
Surg Endosc; 2011 Jun; 25(6):1975-84. PubMed ID: 21140170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
